First-in-Class Device for Facial Wrinkles Hits the Market

  • 📰 Medscape
  • ⏱ Reading Time:
  • 49 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 55%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

Evoke is the first FDA-cleared wearable, hands-free device that uses bipolar radiofrequency to target the lower third of the face and the submental area of the face. DermTwitter

DENVER – One expert's clinical experience suggests that Ellacor, a dermal microcoring device that became available in the United States in October 2022, is an effective treatment for facial wrinkles and tightening."It's early yet, but I have treated dozens of patients with this device, and they have been happy with the results,"

A brainchild of dermatologists and plastic surgeons at Massachusetts General Hospital, Boston, the first-in-class device isby the Food and Drug Administration for the treatment of moderate and severe wrinkles in the mid and lower face in adults aged 22 years or older with Fitzpatrick skin types I-IV. It features a proprietary needle design that makes a series of high throughput microexcisions in epidermal and dermal tissue, with minimal downtime and without using thermal energy.

The device features needle cartridges capable of excising up to 24,000 cores per treatment. According to data from Cytrellis, the manufacturer, the equivalent of about 2 inches of skin can be removed during the procedure, which typically takes fewer than 30 minutes to perform."There is no heat whatsoever," Avram said."In my experience, it especially helps with jawline definition, the lower medial cheek excess skin, and accordion lines in that area.

 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 386. in KR

대한민국 최근 뉴스, 대한민국 헤드 라인